Deeplink Medical SAS

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Deeplink Medical SAS - overview

Established

2014

Location

Lyon, -, France

Primary Industry

Software

About

Based in France, Deeplink Medical SAS specializes in digital healthcare solutions aimed at enhancing patient care through improved connectivity among healthcare professionals. Deeplink Medical SAS, founded in 2014 in Lyon, France, focuses on developing digital healthcare solutions. The company has successfully completed three deals, with its most recent funding round on January 11, 2023, raising EUR 5. 82 mn from investor IMADIS.


The founders, Alexandre CHEIKH and Nicolas Girouin, have a background in healthcare technology and innovation. Deeplink Medical specializes in digital healthcare solutions designed to improve patient care through enhanced connectivity among healthcare professionals. The company's core offerings include ITIS, a platform for managing (tele)radiology examinations; MIRIO, a collaborative platform for oncology patient follow-ups; DLMBox, which facilitates the transfer of images in DICOM format; and DLFlow, a medical questionnaire system aimed at improving patient monitoring. These products are primarily targeted at healthcare providers, including hospitals and outpatient clinics, and are used to streamline processes, enhance communication, and ensure compliance with best practices in the medical field.


Deeplink Medical operates in various geographical markets, focusing significantly on metropolitan France and its overseas territories, where the need for advanced telemedicine and radiology solutions is growing. In 2020, Deeplink Medical reported revenues of EUR 1,956,270. 90 with an EBITDA of EUR -1,956,772. 20, underscoring the ongoing development phase of the company’s innovative solutions and their market penetration strategy.


Following its latest funding round in January 2023, where Deeplink Medical SAS raised EUR 5. 82 mn, the company plans to use this capital to extend and accelerate the dissemination of its existing solutions. Upcoming initiatives include enhancements to their current platforms and potential expansions into new geographical markets, which are being evaluated for their readiness for advanced telemedicine and radiology solutions. This approach aims to meet the growing demand for digital healthcare services in various regions.


Current Investors

Bpifrance, Simba Santé, IMADIS

Primary Industry

Software

Sub Industries

Diagnostic, Medical & Imaging Laboratories, Oncology/Cancer Treatment, Medical Software

Website

www.deeplink-medical.com

Verticals

HealthTech

Company Stage

Angel & Seed

Total Amount Raised

Subscriber access only

Deeplink Medical SAS - financials

Fiscal Year EndedDec 31, 2019Dec 31, 2020
Revenue (USD)--
% Revenue Growth (YoY)--
EBITDA (USD)--
Operating Income (USD)--
Operating Margin--
% EBITDA Margin--
NET Income (USD)--
% Net Margin--
GoingPro

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.